Commodore Gets Transparent on Callback Flip Phone Pricing, Drops $100 Ahead of June 30 Pre-Orders
Tiered pricing brings base price on select models to $399, putting the smarter flip phone in more hands for less DOVER, Del., June 24, 2026 /PRNewswire/ —... Read more.
Findem and RecruitMilitary Launch New Veteran People Intelligence Dataset
Building the intelligence layer that helps AI systems, recruiters and employers better understand military experience and connect veterans to opportunity REDWOOD... Read more.
METLEN inaugurates the 4th production unit of the M Technologies Hub in Volos opening a new chapter for the Greek and European defence industry
ATHENS, Greece and LONDON, June 24, 2026 /PRNewswire/ — METLEN (LSE: MTLN) (RIC: MTLN.L) (Bloomberg: MTLN.LN) (Athens: MTLN) (RIC: MTLNr.AT) (Bloomberg: MTLN.GA)... Read more.
Assort Health Raises $120 Million Series C to Scale Largest Deployment of AI Agents for the Patient Journey
SAN FRANCISCO, June 24, 2026 /PRNewswire/ — Assort Health, the most widely-used AI agents platform for the patient journey, today announced a $120 million... Read more.
Netgain Continues to Reshape Accounting with AI, Previewing a New Consolidation Engine at Its Second Annual Accounting Summit
Consolidations by Netgain is the latest in a steady run of releases built to make the accountant’s workflow easier DENVER, June 24, 2026 /PRNewswire/ —... Read more.
ELEGOO Launches Open-Frame Centauri 2 Series: Bringing Fast, Accessible Multicolor 3D Printing to Everyone
——Open Build, Open to Color SHENZHEN, China, June 24, 2026 /PRNewswire/ — ELEGOO, a rapidly developing brand in global smart manufacturing, today announces... Read more.
RelaxPLX® Gains Health Canada License, and South Korean Sleep Quality Support Claim
The health claims will help drive collaboration with leading international supplement brands MADRID, June 24, 2026 /PRNewswire/ — Monteloeder, SL, a subsidiary... Read more.
Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
Single ascending dose study evaluating safety, tolerability, and pharmacokinetics of VK3019 Potential to further expand Viking’s treatment options for weight... Read more.
REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
Confirmatory study completed ahead of schedule due to strong patient demand and robust investigator interest On track to initiate BLA in Q3 2026 under the accelerated... Read more.
Corvention Announces First Case in the U.S. and Initiates Limited Commercial Launch of Innovative Balloon Cathete
FLAGSTAFF, Ariz., June 24, 2026 /PRNewswire/ — Corvention, an emerging leader in structural heart innovations, today announced the successful completion of... Read more.